Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
Wang, HY, Lee, DA, Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, EM and
Wang, RF (2004). Tumorspecific human CD4+ regulatory T cells and their
ligands: implications for immunotherapy. Immunity 20: 107-118.
Wang, HY, Peng, G., Guo, Z., Shevach, EM and Wang, RF (2005). Recognition
of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-
specific CD4+ regulatory T cells. J. Immunol. 174: 2661-2670.
Wang, RF (2001). The role of MHC class II-restricted tumor antigens and CD4+
T cells in antitumor immunity. Trends Immunol. 22(5): 269-276.
Wang, RF, Wang, X., Atwood, AC, Topalian, SL and Rosenberg, SA (1999a).
Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a
tumor antigen. Science 284: 1351-1354.
Wang, RF, Wang, X. and Rosenberg, SA (1999b). Identification of a novel major
histocompatibility complex class II-restricted tumor antigen resulting from a
chromosomal rearrangement recognized by CD4(+) T cells. J. Exp. Med. 189:
1659-1668.
Watts, C. (2004). The exogenous pathway for antigen presentation on major
histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5: 685-
692.
Wiik, A. (2000). What you should know about PR3-ANCA. An introduction.
Arthritis Res. 2(4): 252-254.
Witko-Sarsat, V., Lesavre, P., Lopez, S., Bessou, G., Hieblot, C., Prum, B., Noel,
LA, Guillevin, L., Ravaud, P., Sermet-Gaudelus, I., Timsit, J., Grünfeld, JP and
Halbwachs-Mercarelli, L. (1999). A large subset of neutrophils expressing
124